title: Hemodynamic changes and circulating recombinant tumor necrosis factor-alpha concentrations in a patient undergoing isolated limb perfusion.
authors: Magill Department of Anaesthetics, England Charing Cross and Westminster Medical School, Westminster Hospital, London, UK.
authors: W J
authors: WJ
authors: Fawcett
authors: S
authors: S
authors: Hill
authors: J
authors: J
authors: Sheldon
authors: T R
authors: TR
authors: Williams
authors: J M
authors: JM
authors: Thomas
authors: P
authors: P
authors: Riches
authors: M E
authors: ME
authors: Gore
authors: N
authors: N
authors: Soni
mesh_terms: D001859:Bone Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000556:secondary; D002294:Carcinoma, Squamous Cell / Q000097:blood / Q000188:drug therapy* / Q000556:secondary; D010478:Chemotherapy, Cancer, Regional Perfusion / Q000379:methods*; D016903:Drug Monitoring; D004359:Drug Therapy, Combination; D005260:Female; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D007378:Interleukins / Q000097:blood; D008558:Melphalan / Q000627:therapeutic use; D008875:Middle Aged; D012983:Soft Tissue Neoplasms / Q000473:pathology*; D013977:Tibia; D013997:Time Factors; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis / Q000494:pharmacology* / Q000627:therapeutic use
chemical_list: D007378:Interleukins; D014409:Tumor Necrosis Factor-alpha; D008558:Melphalan